TL;DR
Researchers often face challenges visualizing complex genomic data from targeted sequencing panels, which are more cost-effective than whole-genome sequencing for many applications. TarPan is a new, web-based tool that simplifies the inspection of mutations, copy number changes, and structural variants from these panels, offering a user-friendly interface and flexible data integration.
What Problem Does This Paper Address?
The field of cancer genomics is rapidly advancing, leading to the discovery of new therapeutic targets and personalized treatment strategies. While whole-genome sequencing provides comprehensive data, it remains prohibitively expensive for routine clinical use. Targeted sequencing panels offer a cost-effective alternative, focusing on specific genomic regions relevant to particular cancers. However, existing genomic viewers, designed for large-scale data, are often cumbersome and resource-intensive when analyzing targeted panel data. This creates a barrier for researchers and clinicians trying to efficiently interpret these valuable datasets, leading to the need for a specialized tool.
Methods
TarPan is built using R Shiny for its web interface, leveraging R's extensive visualization libraries. The backend is powered by SQLite databases, managed by argument-driven Python scripts. This architecture allows for efficient data handling and cross-platform compatibility. The tool accepts standardized input formats like BED and VCF, enabling integration with various bioinformatic algorithms for variant calling (e.g., CNVkit for copy number, Strelka2 for somatic variants, Manta for structural variants, and VEP for annotations). TarPan provides multiple views for copy number analysis, including whole-genome, chromosome-specific, and continuous chromosome views, along with options for manual normalization adjustments. It also offers interactive tables for mutations and structural variants, with search and sort functionalities.
Datasets
The paper demonstrates TarPan's utility using publicly available datasets, including:
- Follicular lymphoma data (from TCRBOA7, Texas Cancer Research Biobank).
- Breast cancer cell line data (HCC2218C from Illumina Basespace).
- Multiple myeloma data (100 samples from European Genome Archive accession EGAS00001002859).
- Lung cancer data (from UAMS Cancer Institute).
The authors also provide example data in their GitHub repository for multiple myeloma samples.
Key Insights and Ideas
- Bridging the Gap: TarPan effectively addresses the specific needs of targeted sequencing data visualization, which is underserved by general-purpose genomic browsers.
- Flexibility is Key: The tool's adaptability to various cancer types and sequencing panels, along with its ability to integrate data from different bioinformatic pipelines, makes it highly versatile.
- User-Centric Design: The intuitive web interface, coupled with clear visualization options and interactive tables, significantly lowers the barrier to entry for data interpretation.
- Clinical Potential: The authors suggest that TarPan could evolve into a cost-effective diagnostic tool for clinical settings, especially for cancers requiring rapid analysis.
Key Results
TarPan successfully visualizes copy number variations, mutations, and structural variants from targeted sequencing panels. The tool has been internally validated by bioinformaticians and cancer biologists and has been used in high-impact peer-reviewed publications. Case studies demonstrate its effectiveness in analyzing multiple myeloma, follicular lymphoma, breast cancer, and lung cancer data, highlighting specific genomic events like bi-allelic TP53 inactivation, copy number amplifications, and translocations. The tool's fast and responsive interface runs on standard browsers, and its installation is straightforward.
Limitations and Future Work
The authors acknowledge several areas for future development:
- Tumor-Only Sample Processing: Enhancing TarPan to process tumor-only samples would be beneficial when paired normal samples are unavailable, such as in cell line data.
- User Annotation View: Implementing a feature for users to manually annotate features of interest would add another layer of utility.
- Cross-Species Support: Expanding TarPan's compatibility beyond human genomic data (hg19 and hg38) to include other species, like mouse, would broaden its applicability.
- Clinical Diagnostic Aid: Adapting the tool to automatically generate reports or summaries for cost-effective clinical diagnostic tests, with manual validation by a scientist, is a promising future direction.
Summary updated